adriane fugh berman

Adriane Fugh-Berman MD is principal investigator (PI) of the PharmedOut project.

PharmedOut is an independent, publicly funded Georgetown University Medical Center project that educates physicians about industry influence on prescribing. project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices.

PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

Adriane Fugh-Berman MD is principal investigator (PI) of the PharmedOut project.

PharmedOut is an independent, publicly funded project that empowers physicians to identify and counter inappropriate pharmaceutical promotion practices.

PharmedOut promotes evidence-based medicine by providing news, resources, and links to pharma-free CME courses.

MedInformaticsMD noted the impending release of documents about how Wyeth engineered ghost-writing of articles about hormone replacement therapy (HRT) here.

Now the NY Times has had a chance to review the documents, with fascinating results.

The scope of the ghost-writing campaign was on an impressively industrial scale: 26 articles published over 7 years in 18 medical journals.

On the Bioethics Forum, Dr Adriane Fugh-Berman and Dr Douglas Melnick discuss what appears to be the latest example of disease-mongering.

We have posted several times about the inside view of the marketing tactics used by pharmaceutical representatives to get physicians to prescribe more drugs provided by former Eli Lilly drup rep Shahram Ahari.

Our post about an article he co-wrote with Adriane Fugh-Berman is here.

Our post about a recent talk he gave in Boston is here.